Serum β-Defensin 2, A Novel Biomarker for the Diagnosis of Acute Infections.

John G RoutsiasDionysia MarinouMaria MavrouliAthanassios Tsakris Vassiliki C Pitiriga

Published in: Diagnostics (Basel, Switzerland) (2023)

hBD2 has the potential to serve as a diagnostic biomarker for infection. In addition, the levels of hBD2 may reflect the efficacy of antibiotic treatment.

Keyphrases

liver failure
drug induced
aortic dissection
risk assessment
climate change
extracorporeal membrane oxygenation